| Year |
Citation |
Score |
| 2022 |
Nieto SJ, Enders CK, Witkiewitz K, O'Malley SS, Ray LA. Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels. Alcoholism, Clinical and Experimental Research. 46: 2258-2266. PMID 36515648 DOI: 10.1111/acer.14953 |
0.307 |
|
| 2019 |
Falk DE, O'Malley SS, Witkiewitz K, Anton RF, Litten RZ, Slater M, Kranzler HR, Mann KF, Hasin DS, Johnson B, Meulien D, Ryan M, Fertig J. Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials. Jama Psychiatry. PMID 30865232 DOI: 10.1001/Jamapsychiatry.2018.3079 |
0.303 |
|
| 2018 |
O'Malley SS, Todtenkopf MS, Du Y, Ehrich E, Silverman BL. Effects of the Opioid System Modulator, Samidorphan, on Measures of Alcohol Consumption and Patient Reported Outcomes in Adults with Alcohol Dependence. Alcoholism, Clinical and Experimental Research. PMID 30055046 DOI: 10.1111/acer.13849 |
0.303 |
|
| 2015 |
Rojewski AM, Morean ME, Toll BA, McKee SA, Krishnan-Sarin S, Green BG, Bartoshuk LM, O'Malley SS. The Yale Craving Scale: Development and psychometric properties. Drug and Alcohol Dependence. 154: 158-66. PMID 26183404 DOI: 10.1016/J.Drugalcdep.2015.06.040 |
0.308 |
|
| 2013 |
Bujarski S, O'Malley SS, Lunny K, Ray LA. The effects of drinking goal on treatment outcome for alcoholism. Journal of Consulting and Clinical Psychology. 81: 13-22. PMID 23231573 DOI: 10.1037/A0030886 |
0.31 |
|
| 2008 |
Leeman RF, McKee SA, Toll BA, Krishnan-Sarin S, Cooney JL, Makuch RW, O'Malley SS. Risk factors for treatment failure in smokers: relationship to alcohol use and to lifetime history of an alcohol use disorder. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 10: 1793-809. PMID 19023831 DOI: 10.1080/14622200802443742 |
0.323 |
|
| 2007 |
Leeman RF, Huffman CJ, O'Malley SS. Alcohol history and smoking cessation in nicotine replacement therapy, bupropion sustained release and varenicline trials: a review. Alcohol and Alcoholism (Oxford, Oxfordshire). 42: 196-206. PMID 17526629 DOI: 10.1093/Alcalc/Agm022 |
0.315 |
|
| 2007 |
McKee SA, Falba T, O'Malley SS, Sindelar J, O'Connor PG. Smoking status as a clinical indicator for alcohol misuse in US adults. Archives of Internal Medicine. 167: 716-21. PMID 17420431 DOI: 10.1001/Archinte.167.7.716 |
0.306 |
|
| 2005 |
Toll BA, Cooney NL, McKee SA, O'Malley SS. Correspondence between Interactive Voice Response (IVR) and Timeline Followback (TLFB) reports of drinking behavior. Addictive Behaviors. 31: 726-31. PMID 15975732 DOI: 10.1016/J.ADDBEH.2005.05.044 |
0.322 |
|
| 2003 |
O'Malley SS, Froehlich JC. Advances in the use of naltrexone: an integration of preclinical and clinical findings. Recent Developments in Alcoholism : An Official Publication of the American Medical Society On Alcoholism, the Research Society On Alcoholism, and the National Council On Alcoholism. 16: 217-45. PMID 12638640 |
0.308 |
|
| 1999 |
Sinha R, O'Malley SS. Craving for alcohol: Findings from the clinic and the laboratory Alcohol and Alcoholism. 34: 223-230. PMID 10344782 DOI: 10.1093/alcalc/34.2.223 |
0.31 |
|
| 1989 |
Suh CS, O'Malley SS, Strupp HH, Johnson ME. The Vanderbilt Psychotherapy Process Scale (VPPS) Journal of Cognitive Psychotherapy: An International Quarterly. 3: 123-154. DOI: 10.1891/0889-8391.3.2.123 |
0.478 |
|
| 1984 |
O'Malley SS, Maisto SA. Factors affecting the perception of intoxication: Dose, tolerance, and setting Addictive Behaviors. 9: 111-120. PMID 6741674 DOI: 10.1016/0306-4603(84)90049-2 |
0.351 |
|
| 1983 |
O'Malley SS, Suh CS, Strupp HH. The Vanderbilt Psychotherapy Process Scale: a report on the scale development and a process-outcome study. Journal of Consulting and Clinical Psychology. 51: 581-6. PMID 6619366 DOI: 10.1037/0022-006X.51.4.581 |
0.46 |
|
| Show low-probability matches. |